The two-day symposium aims to bring oncologists and statisticians together to share new research, discuss novel ideas, ask questions and provide solutions for cancer clinical trials. In the era of big data, precision medicine, and genomics and immune-based oncology, it is crucial to provide a platform for interdisciplinary dialogues among clinical and quantitative scientists. The OncoStat Annual Symposium serves as a venue for oncologists and statisticians to communicate their views on trial design and conduct, drug development, and translations to patient care. To be discussed includes big data and genomics for oncology clinical trials, novel dose-finding designs, drug combinations, immune oncology clinical trials, and umbrella/basket oncology trials. An important aspect of OncoStat is the participation of researchers across academia, industry, and regulatory agency.
This symposium series started in 2017 at the Stanford University (http://med.stanford.edu/cisd/events/symposium-May2017.html) as an joint event between Stanford University and the University of Chicago. We extended our partnership with University of Connecuticut this year and changed the Symposium name to OncoStat. This symposium is intended to be an annual event that rotates its location at Stanford University, the University of Chicago, and the University of Connecticut.
Half-day short course on Dose-Finding Designs;
Half-day Invited Talks
Keynote and Invited TalksSee PROGRAM for detail.